医学
原发性甲状旁腺功能亢进
队列
闪烁照相术
背景(考古学)
核医学
回顾性队列研究
甲状旁腺切除术
甲状旁腺功能亢进
内科学
PET-CT
放射科
正电子发射断层摄影术
甲状旁腺激素
钙
古生物学
生物
作者
Eugénie Koumakis,Mathieu Gauthé,Alessandro Martinino,Rémy Sindayigaya,Thierry Delbot,M. Wartski,Jérôme Clerc,Christian Roux,Didier Borderie,Béatrix Cochand‐Priollet,Catherine Cormier,Sébastien Gaujoux
标识
DOI:10.1210/clinem/dgad073
摘要
Abstract Context The contribution of [18F]F-fluorocholine (FCH)-positron emission tomography (PET)/computed tomography (CT) in normocalcemic primary hyperparathyroidism (nPHPT) remains unknown. Objective To evaluate the sensitivity and specificity of FCH-PET/CT in a cohort of osteoporotic patients with nPHPT and discordant or negative [99mTc]Tc-sestamibi scintigraphy and ultrasonography who all underwent parathyroidectomy (PTX). Design Longitudinal retrospective cohort study in patients referred for osteoporosis with mild biological primary hyperparathyroidism. Setting Tertiary referral center with expertise in bone metabolism and surgical management of hyperparathyroidism. Patients Among 109 patients with PHPT analyzed, 3 groups were individualized according to total serum calcium (tCa) and ionized calcium (iCa): 32 patients with hypercalcemia (HtCa group), 39 patients with normal tCa and elevated iCa (NtCa group), and 38 patients with both normal tCa and iCa (NiCa). All patients had biochemical follow-up confirming or not the success of PTX. Main outcome measures To evaluate the performance of FCH-PET/CT in terms of sensitivity and specificity, and to compare with first-line imaging procedures in the setting of nPHPT. Results The sensitivity of FCH-PET/CT was 67% in the hypercalcemic group, 48% in the NtCa group (P = .05 vs HtCa), and 33% in the NiCa group (P = .004 vs HtCa). Specificity ranged from 97% to 99%. FCH-PET/CT was positive in 64.3% of patients with negative conventional imaging, with biochemical resolution after PTX in 77.8% of patients. Triple negative imaging was observed in 20 patients, with PHPT resolution in 85% of these patients. Conclusion This study highlights the contribution of FCH-PET/CT in a well-phenotyped cohort of normocalcemic patients with discordant or negative findings in [99mTc]Tc-sestamibi scintigraphy and ultrasonography. However, negative imaging in nPHPT does not rule out the possibility of surgical cure by an experienced surgeon.
科研通智能强力驱动
Strongly Powered by AbleSci AI